Skip to content

Psychiatriki

ISSN 1105-2333

9 papers in the library · 4 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

Timing and self distortions in psychosis: Is it an insula matter?

Psychiatriki February 19, 2026 Orestis Giotakos

The concept of timing is an interesting way to understand how the body and brain construct the concept of self, but also how self-distortions arise in the case of psychosis. Analysis of temporal representations in psychosis highlights a deficit that includes both the subjective experience of the flow of time, i.e., time perception, and the ability to process temporal information inherent to any...

[Hypnosis: An ancient therapeutic practice revived in modern science].

Psychiatriki July 2, 2025 Dimitrios Sakellion, Shokhrukh Sultanov, Dilmurad Irgashev et al.

Hypnosis is an externally induced alteration in consciousness as a result of suggestion. Hypnotherapy, also called clinical hypnosis, is the use of hypnosis as psychological treatment, either brief or long-term psychotherapy, for alleviating pain, inducing habit modification, and treating a range of physical and mental health problems, such as psychosomatic diseases, mood and anxiety disorders,...

DOI: 10.22365/jpsych.2025.006 (opens in new tab) Full text (opens in new tab) Catalepsy Encephalogram Hypnotherapy hypnosis Therapeutic approach +6

Results of esketamine administration in a Greek population; A case series.

Psychiatriki October 8, 2024 Petros Fotiadis, Eleni Tsalkitzi, Dimos Dimellis et al.

Esketamine is a non-selective, competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor in the brain. Through NMDA receptor antagonism, esketamine causes a transient increase in glutamate release, leading to increases in neurotrophic signaling and restoration of synaptic function in brain regions involved in mood regulation and emotional behavior. Several randomized clinical trials...

DOI: 10.22365/jpsych.2024.006 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Fast-acting antidepressant Mood disorders Therapeutic intervention +5

Modelling disruptions of intentionality in psychosis.

Psychiatriki October 12, 2023 Orestis Giotakos 1 citation

In philosophy, intentionality involves directedness, aboutness, or reference of mental states. It seems to have intense connections with mental representation, consciousness, as well as evolutionary selected functions. Naturalizing intentionality, in terms of tracking or functional roles, is one of the most important goals in philosophy of mind. Such what-matters models would be useful,...

DOI: 10.22365/jpsych.2023.002 (opens in new tab) Full text (opens in new tab) Intentionality Aboutness Cusp catastrophe model Directedness +2

Ketamine infusion therapy in treatment-resistant depression

Psychiatriki December 20, 2021 Τheodosios Ε Christodoulakis 1 citation

Τhe Food and Drug Administration (FDA) approval of the use of S-ketamine in the form of nasal spray for the treatment of treatment-resistant depression, launched a new category of therapeutic agents in psychiatry. A well-known class of substances, psychedelics, are introduced with a 30-year delay in the treatment of mental disorders. Intravenous ketamine infusion has been studied in the...

Electroconvulsive therapy in treatment resistant depression: What is new?

Psychiatriki December 20, 2021 Styliani Kaliora 1 citation

Despite major advances in the treatment of mood disorders, major depression, a common mental disorder, remains a serious public health problem. Electroconvulsive therapy (ECT) regardless of the anesthetic agent used, is the most effective form of treatment in major depression and the gold standard therapy in treatment resistant depression. Ketamine is one of the anesthetic drugs approved by the...

The role of ketamine in the treatment of treatment-resistant bipolar depression

Psychiatriki December 20, 2021 Grigorios N. Karakatsoulis, Eva-Maria Tsapakis, Konstantinos Ν. Fountoulakis 1 citation

Treatment-Resistant Depression (TRD) calls for the development of effective interventions for mood elevation and stabilization. Recently, both ketamine and its S-enantiomer (esketamine) have been investigated with successful clinical trials demonstrating effectiveness in TRD. More specifically, in 2019, intranasally administered esketamine, as opposed to the more effective intravenous ketamine,...

Drugs for mental illnesses in ancient greek medicine.

Psychiatriki 2019 K Laios, P Lytsikas-Sarlis, K Manes et al.

Drugs with psychedelic, hypnotic, narcotic, analgesic, suppressive, euphoric and stimulating effects were used in various ways during the ancient times. We can classify drug use in ancient times into two main categories. On the one hand, ancient physicians prescribed drugs based on their pharmaceutical-therapeutic actions. On the other hand, people not pertaining to medicine and not relating to...

[Poor insight and psychosis].

Psychiatriki 2017 O Giotakos

A variety of phenomena might be considered as reflecting impaired insight in psychosis, like failure to recognize signs, symptoms or disease, failure to derive appropriate cognitive representations, despite recognition of the disease, and misattribution of the source or cause of the disease. The unawareness of tardive dyskinesia symptoms in schizophrenic patients points that self-awareness...